AI assistant
Adicet Bio, Inc. — Director's Dealing 2020
Oct 28, 2020
34412_dirs_2020-10-27_34d624b5-ea5d-4d9d-b5fa-5d3860ea9ed6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2020-10-23
Reporting Person: Schor Chen (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-10-23 | Common Stock | F | 8649 | $0.00 | Disposed | 72499 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 223908 | Indirect |
Footnotes
F1: The Reporting Person is disposing of 8,649 restricted stock units as a result of a revised tax rate for such restricted stock units.
F2: Represents 85,623 shares held directly by an irrevocable family trust having an independent trustee, 3,571 shares held by a revocable family trust of which the Reporting Person is the trustee, 91,857 shares held directly by an irrevocable family trust having an independent trustee, 3,571 shares held directly by a revocable trust of which the spouse is the trustee and 39,286 shares held directly by a grantor retained annuity trust of the spouse.